Release Date: February 14, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide an update on the IONWAY program, including the timeline and expected returns on equity injections? A: Wannes Peferoen, CFO: We are on track with IONWAY, with capital injections being front-loaded due to the lengthy project financing process. We expect financing to be in place by the second half of 2026. While we can't share specific commercial details, we remain confident in the project's value creation.
Q: How might Umicore be impacted by trade tariffs, and why is CapEx in Battery Materials not reduced further despite low EBITDA? A: Bart Sap, EVP Catalysis: Trade tariffs are unpredictable, but we have an agile footprint and diversified supply base to mitigate impacts. CapEx in Battery Materials is focused on debottlenecking the Korean plant to meet customer commitments, despite the pause in Canada.
Q: Are there any considerations to exit larger contracts in Battery Materials to reduce CapEx, and will Umicore generate positive free cash flow in 2025? A: Bart Sap, EVP Catalysis: We are committed to our customer contracts and are building against these commitments. Wannes Peferoen, CFO: Free cash flow will be negative in 2025 due to equity contributions to IONWAY and CapEx, with leverage expected to increase.
Q: What are the remaining restructuring costs, and how will metal hedge roll-offs impact 2025 and 2026? A: Wannes Peferoen, CFO: The cash out for restructuring in 2025 is approximately EUR70 million. Metal hedge roll-offs will impact 2025, with further effects expected in 2026.
Q: Can you clarify the funding structure for the IONWAY investment and any risks to the debt-to-equity components? A: Wannes Peferoen, CFO: We aim to fund at least 50% of IONWAY's needs through debt financing. Equity contributions are front-loaded, with EUR400 million expected in 2025. Inflation has affected the project, but we have strong guardrails in place.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.